Total Payments
$4,013
2024 Payments
$1,797
Companies
19
Transactions
166
Medicare Patients
9,071
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$3,904 (97.3%)
Education$108.40 (2.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,904 | 164 | 97.3% |
| Education | $108.40 | 2 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $889.93 | 28 | $0 (2024) |
| ABBVIE INC. | $806.80 | 45 | $0 (2024) |
| Janssen Biotech, Inc. | $625.56 | 24 | $0 (2024) |
| Galderma Laboratories, L.P. | $403.07 | 8 | $0 (2024) |
| PFIZER INC. | $216.94 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $156.91 | 6 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $151.18 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $128.79 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $111.42 | 5 | $0 (2024) |
| Lilly USA, LLC | $97.05 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,797 | 101 | ABBVIE INC. ($404.60) |
| 2023 | $1,246 | 51 | ABBVIE INC. ($402.20) |
| 2022 | $158.31 | 3 | GENZYME CORPORATION ($138.87) |
| 2021 | $488.92 | 7 | GENZYME CORPORATION ($269.04) |
| 2019 | $145.34 | 2 | Galderma Laboratories, L.P. ($125.00) |
| 2018 | $176.83 | 2 | Galderma Laboratories, L.P. ($92.32) |
All Payment Transactions
166 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: DERMATOLOGY | ||||||
| 12/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.48 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Immunology | ||||||
| 12/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $41.49 | General |
| Category: Immunology | ||||||
| 12/05/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Immunology | ||||||
| 11/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Immunology | ||||||
| 10/30/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: DERMATOLOGY | ||||||
| 10/28/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: DERMATOLOGY | ||||||
| 10/24/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.43 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Immunology | ||||||
| 10/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $28.57 | General |
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Immunology | ||||||
| 10/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.35 | General |
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.54 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,032 | 3,343 | $778,620 | $157,592 |
| 2022 | 24 | 1,731 | 2,717 | $762,045 | $390,249 |
| 2021 | 31 | 3,318 | 5,036 | $1.1M | $606,952 |
| 2020 | 12 | 1,990 | 3,364 | $270,790 | $142,707 |
Total Patients
9,071
Total Services
14,460
Medicare Billing
$1.3M
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 344 | 417 | $123,849 | $28,160 | 22.7% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 31 | 35 | $78,715 | $17,087 | 21.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 187 | 204 | $77,112 | $16,775 | 21.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 202 | 202 | $74,538 | $15,785 | 21.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 221 | 230 | $77,740 | $15,277 | 19.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 333 | 375 | $83,625 | $12,992 | 15.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 80 | 85 | $47,770 | $10,833 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 97 | $40,740 | $9,226 | 22.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 262 | 1,335 | $30,705 | $6,804 | 22.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 25 | 27 | $27,297 | $5,924 | 21.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $22,427 | $4,953 | 22.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 32 | 32 | $13,408 | $3,072 | 22.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 62 | 72 | $12,096 | $2,766 | 22.9% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Facility | 2023 | 17 | 17 | $26,656 | $1,955 | 7.3% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 15 | $12,195 | $1,403 | 11.5% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 11 | 13 | $12,051 | $1,386 | 11.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 26 | $4,836 | $1,076 | 22.2% |
| 10040 | Acne surgery | Office | 2023 | 12 | 12 | $4,644 | $1,021 | 22.0% |
| 69100 | Biopsy of ear | Office | 2023 | 16 | 17 | $5,457 | $774.44 | 14.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 25 | $1,175 | $269.25 | 22.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 66 | $1,584 | $54.99 | 3.5% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 148 | 184 | $161,000 | $89,711 | 55.7% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 141 | 197 | $103,425 | $62,672 | 60.6% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 89 | 123 | $97,785 | $57,548 | 58.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 141 | 174 | $65,250 | $30,187 | 46.3% |
About Dr. Jeffrey Harbold, DO
Dr. Jeffrey Harbold, DO is a Dermatology healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2015. The National Provider Identifier (NPI) number assigned to this provider is 1700260197.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Harbold, DO has received a total of $4,013 in payments from pharmaceutical and medical device companies, with $1,797 received in 2024. These payments were reported across 166 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,904).
As a Medicare-enrolled provider, Harbold has provided services to 9,071 Medicare beneficiaries, totaling 14,460 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Tyler, TX
- Active Since 07/15/2015
- Last Updated 08/01/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1700260197
Products in Payments
- DUPIXENT (Biological) $971.80
- TREMFYA (Drug) $713.39
- SKYRIZI (Biological) $491.20
- RINVOQ (Biological) $307.15
- EUCRISA (Drug) $194.63
- ILUMYA (Biological) $128.69
- SOOLANTRA (Drug) $125.00
- ORACEA (Drug) $107.05
- Sotyktu (Drug) $97.85
- TALTZ (Drug) $97.05
- EPIDUO FORTE (Drug) $92.32
- OPZELURA (Drug) $89.39
- ADBRY (Biological) $55.02
- Zoryve (Drug) $44.66
- Otezla (Drug) $43.91
- VTAMA (Drug) $36.57
- LIBTAYO (Biological) $29.55
- COSENTYX (Drug) $29.34
- Bimzelx (Biological) $22.86
- BLU-U (Medical Supply) $22.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Tyler
Jennifer Holman, Md, MD
Dermatology — Payments: $705,235
Dermatology $705,235
Lindsey Hunter-Ellul, Md, MD
Dermatology — Payments: $11,358
Dermatology $11,358
Martha Mccollough, Md, MD
Dermatology — Payments: $10,842
Dermatology $10,842
Leslie Markle, Md, MD
Dermatology — Payments: $8,660
Dermatology $8,660
Alma Berlingeri Ramos, Md, MD
Dermatology — Payments: $4,757
Dermatology $4,757
Bradley Graham, Md, MD
Dermatology — Payments: $3,625
Dermatology $3,625